Pembrolizumab and Odetiglucan in Liver Predominant Metastatic Colorectal Adenocarcinoma — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(1 site)
United States
Abramson Cancer Center at the University of Pennsylvania, Philadelphia, Pennsylvania Last updated September 2025